Capoten (captopril) is a small molecule pharmaceutical. Captopril was first approved as Capoten on 1982-01-01. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme. In addition, it is known to target angiotensin converting enzyme.
|Indication||bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, raynaud disease, rheumatoid arthritis|
|Drug Class||Aptamers, classical and mirror; antihypertensives (ACE inhibitors)|